The proposed pilot program that would change how Medicare pays for certain drugs under Medicare Part B is facing little support in Congress. Many congressional members joining together voicing their concerns about the harm this program could have on patients by limiting their access to treatments if doctors’ costs to acquire drugs become higher than the Medicare reimbursement rate. Read article here…..
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.